A chemist based at the University of Copenhagen has just taken out a patent for a drug that can make previously multidrug-resistant bacteria responsive to antibiotics once again.
Jørn Bolstad and his chemist colleagues hope that the substance will soon be able to tackle the tremendous problems associated with multidrug resistant tuberculosis (MDR-TB). But first, they need to find investors interested in getting the substance onto the market.
Before the development of penicillin, people dropped like flies in response to minor infections: in the lungs, in small cuts. Even pimples could grow to boils that killed. But one of the main killers prior to the discovery of antibiotics was tuberculosis.
The deadly infectious disease that typically affects the lungs has returned. It has developed a resistance to the majority of antibiotics that would otherwise kill the tuberculosis bacteria. Currently, the disease does not pose an imminent threat to Denmark or the West. However, resistant strains of the bacteria are nearing the region’s borders. This is one of the reasons why doctors around the world are busy trying to solve the problem of drug resistance.
The bacteria shed killing substances
While those bacteria that have developed a resistance remain vulnerable to antibiotics, they have developed an ability to shed bacteria killing substances before any damage is done to them. Colloquially, this is referred to as pooping the substance out, but the scientific formulation is that these bacteria activate an efflux pump.
Jørn Bolstad Christensen has isolated a substance able to block the efflux pump so that an antibiotic remains in bacteria until the bacteria dies.
You could say that we cure bacteria of their resistance, and slay them with antibiotics, explains Associate Professor Jørn Bolstad Christensen.
From antipsychotic to killing bacteria
Working with doctors Jette Kristiansen from the University of Southern Denmark and Oliver Hendricks from the King Christian X’s Hospital for Rheumatic Diseases in Gråsten, Denmark, Jørn Bolstad Christensen discovered that Thioridazin, an antipsychotic drug, was able to kill bacteria without any noticeably harmful effects upon humans. Still, the chemists had an idea that could make the substance more benign.
We now have a substance that is able to block the bacteria’s efflux pump. At very most, recipients of the medication may become slightly sluggish. This is also because very small doses are needed to affect the bacteria, says Jørn Bolstad Christensen.
Researchers hope for quick approval
Because Thioridazin is an approved drug, the research team hopes that the new anti-resistance medication, JEK 47, will be approved without going through the entire process that new pharmaceuticals are typically subjected to. If this is the case, JEK 47 will most likely be a cheap medication that a pharmaceuticals manufacturer could release quickly. However if an investor does not show interest, Christensen is certain about his next step.
The Latest on: Antibiotic resistance
[google_news title=”” keyword=”Antibiotic resistance” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Antibiotic resistance
- Antimicrobial-resistant E. coli found in dogs with diarrheaon February 29, 2024 at 6:40 am
A team of Chinese veterinary researchers has found high levels of antimicrobial-resistant Escherichia coli in dogs with diarrhea. In their study, published in the open access journal PLOS ONE, the ...
- More than HALF of pet dogs are carrying antibiotic-resistant superbugs in their diarrhea that spreads easily to humans, study revealson February 28, 2024 at 1:53 pm
The majority of dogs in the study carried bacteria that can't be killed with drugs Unregulated over-prescribing of antibiotics has led to a drug resistance crisis READ MORE: Scientists discover new ...
- Dog Owners Issued Health Warning Over Drug-Resistant Bacteriaon February 28, 2024 at 11:00 am
It can usually be treated with the antibiotic ciprofloxacin, but scientists are discovering that some strains of E. coli have become resistant to antibiotics, making them more of a danger. Chinese ...
- Harvard Scientists Breakthrough Antibiotic Resistance With Synthetic Superbug Slayeron February 28, 2024 at 3:35 am
Cresomycin, a groundbreaking antibiotic developed by Harvard scientists, targets drug-resistant bacteria with improved binding to ribosomes, offering hope against global antimicrobial resistance. A ne ...
- Global epistasis in plasmid-mediated antimicrobial resistanceon February 26, 2024 at 6:58 am
Antimicrobial resistance (AMR) in bacteria is a major public health threat and conjugative plasmids play a key role in the dissemination of AMR genes among bacterial pathogens. Interestingly, the ...
- Miniature terminator dishes out droplets to decimate drug-resistant bacteriaon February 23, 2024 at 11:03 am
Johns Hopkins researchers have developed a possible solution called RoboDrop: a robotic platform capable of rapidly screening multiple combinations of antibiotics simultaneously to find the most ...
- Copies of antibiotic resistance genes greatly elevated in humans and livestockon February 23, 2024 at 7:56 am
Researchers have uncovered a key link between the spread of antibiotic resistance genes and the evolution of resistance to new drugs in certain pathogens. Bacteria exposed to higher levels of ...
- Key link discovered between spread of antibiotic resistance genes and drug resistance evolutionon February 23, 2024 at 5:58 am
Biomedical engineers at Duke University have uncovered a key link between the spread of antibiotic resistance genes and the evolution of resistance to new drugs in certain pathogens.
- Curbing Antibiotic Use Workson February 22, 2024 at 4:01 pm
A decline in antibiotic-resistant bacteria has been observed in European countries that have curbed the use of antibiotics in both animals and humans, revealed the fourth joint interagency ...
- Antibiotic Resistance Genes Elevated in Humans and Livestockon February 22, 2024 at 4:01 pm
Biomedical engineers at Duke University have uncovered a key link between the spread of antibiotic resistance genes and the evolution of resistance to new drugs in certain pathogens. The research ...
via Bing News